Viral Clearance Market Size, Share & Industry Forecast 2027
                     *Global Viral Clearance Market 
By Method, By Application, By 
End User, By Region
*The global viral clearance market was valued at US$ 319.6 Million in 2019 
and is projected to reach US$ X,XXX.1 Million by 2027, expanding at a 
CAGR of 20.6% during the forecast period. The market is driven by 
factors such as increasing government funding for the pharmaceutical 
and biotechnology industries, rise in number of new drug launches, R&D 
investments in life science, technology advancements in nanofiltration, 
and increase in emphasis on quality assurance and quality control 
departments.
*
On the basis of methods, the market is segmented into viral removal and 
viral inactivation. The viral removal is sub-segmented into 
chromatography, nanofiltration, and precipitation. The chromatography 
segment is expected to account for a significant share of the market 
between 2020 and 2027. Adoption of new technology and increasing need 
for filtration drive the demand for nanofiltration. The nanofiltration 
segment is expected to expand at a CAGR of XX.0% during the forecast 
period. The viral inactivation segment is further divided into low pH, 
solvent detergent method, pasteurization, and others. The low pH 
segment is estimated to expand at a X0.6% CAGR in the forecast period, 
between 2020 and 2027.

*The viral removal segment accounted for the dominant share of the 
market in 2019. This segment is also expected to expand at a XX.7% 
CAGR, in the the forecast period, between 2020 and 2027. The significant 
share of this segment is primarily attributed to the growth of R&D 
activities by biopharmaceutical companies; high acceptance of this 
method; and the accuracy, speed, and flexibility provided by the method 
in life sciences research.
Based on applications, the global viral clearance market is segregated 
into recombinant protein, blood and blood products, vaccines, cell and 
gene therapy, monoclonal antibody, stem cell, hormones, and others. 
The recombinant proteins segment is expected to dominate the market 
during the forecast period due to large-scale production of recombinant 
protein, it finds it’s application in  applications in the field of 
proteomics, structural biology, and protein therapeutics. When large 
quantities of protein needs to be produced, cells must be cultured in 
large volumes by the implementation of fermentation techniques, as the 
production of these proteins increases the demand for the viral clearance 
process. The stem cell segment is estimated to expand at a CAGR of 
21.2% during the forecast period, due to the increasing use of stem cell 
in the treatment of various diseases, rising public and private funding for 
stem cell research, and growing awareness about stem cell therapies. 
*On the basis of end-users, the viral clearance market is Classified 
as medical device companies, laboratories, animal facilities, cell 
banks, and consultants, and media/sera manufacturers, 
pharmaceutical & biotechnology companies, contract research 
organizations (CROs), academic research institutes, and others. 
The contract research organizations  (CROs) segment is expected 
to register a CAGR of 20.9% between 2020 and 2027. Rapid growth 
in this segment is attributed to the ability of CROs to invest in 
infrastructure for drug discovery and rising trend of outsourcing 
drug discovery services to CROs by pharmaceutical companies, 
academic institutes, and biotechnology companies.
*Request Sample Report: 
https://growthmarketreports.com/request-sample/5
*Global Viral Clearance Market Segment
* In terms of regions, the market has been fragmented into North 
America, Europe, Asia Pacific, Latin America, and Middle East & 
Africa. The market in Asia Pacific is anticipated to expand at a 
CAGR of 21.1% during the forecast period,. Rise in funding for 
medical research, large presence of a large number of CROs to 
provide preclinical and clinical research services in China, increase 
in aging population, growth in pharmaceutical R&D expenditures in 
emerging countries such as India, China, and surge in 
pharmaceutical manufacturing boost the growth of the viral 
clearance market in Asia Pacific.
North America is expected to account for a significant share of the 
market. The market in the region is driven by the growth in the 
pharmaceuticals industry and rising number of drug approvals. 
Increasing prevalence of diseases, growing production of 
monoclonal antibodies, and rising government support for the 
development of drugs are some factors driving the viral clearance 
market.
 
* Global Viral Clearance Market Regional 
Outlook
*Key players in the market include Wuxi Biologics, Merck KGaA,  and 
 Charles River Laboratories International Inc. They considered as 
key players in the market based on their different varieties of 
product availability, regional presence, better supply chain 
management system, and increasing demand for products.
*Global Viral Clearance Market Major Player Anlaysis
Report Attribute GloRbeaplo Vrti rDaelt aCillesarance Market Report Attribute
Base Year 2019    
Historical Data 2017
Forecast Year 2027
Growth Rate 20.6%
Market Value in 2019 US$ 319.6 Million
Global - North America, Europe, China, Rest of Asia 
Regional scope Pacific, Central & South America, and the Middle 
East & Africa 
By Method (Viral Removal, Viral Inactivation), By 
Application (Recomninant Protein, Blood & Blood 
Products, Vaccines, Cell & Gene Therapy, 
Segments covered Monoclonal Antibody, Stem Cell, Hormones, 
Others), By End User (Pharmaceutical & 
Biotechnology Companies, Contract Research 
Organisation, Academic Research Institues, Other)
WuXi Biologics,CHARLES RIVER LABORATORIES 
INTERNATIONAL, INC,Merck KGaA,Texcell 
Key companies profiled SA,Kedrion S.p.A,Lonza,VIRUSURE,Vironova,Eurofins 
Scientific,Cleancells